Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05720000
Other study ID # PCG
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 25, 2023
Est. completion date August 23, 2023

Study information

Verified date March 2024
Source University of Nove de Julho
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Physical appearance is a factor that contributes to an individual's self-esteem. Maintaining a healthy appearance is a growing quest by the population, and aging is the main cause of discomfort for men and women. There are several aesthetic treatments capable of mitigating or delaying the effects of aging in all its layers of alteration (dermis, hypodermis, musculature and bone), and the combination of therapies has been increasingly proposed in search of a positive synergy. The dermal application of polydioxanone threads (PDO) and the low-power red LED (photobiomodulation - PBM) are individual options of resources for which there already are reports in the literature about their mechanisms of action in the proliferation of fibroblasts and collagen production. However, the joint application of these techniques requires further studies. A total of 40 patients, aged between 30 and 60 years old, phototypes I-IV in Fitzpatrick scale, Glogau 3-4, presenting static wrinkle at the glabellar region will be recruited and distributed among 2 groups: PDO thread + PBM or PDO thread + sham PBM. The treatments will consist of 30 days, with one application of PDO thread and PBM twice a week (total of 9 sessions).


Description:

This is a controled, randomized, double blind, two arms clinical trial. The main objective of this study is to evaluate the effect of PBM with red light associated to PDO threads in individuals with static wrinkles in the glabellar region in terms of oedema, dermal thickening and PDO thread hydrolysis. The sample will be divided into 2 groups: Group 1 will receive PDO thread and PBM with Red LED (Newskin, MMO), 150 milliwatt (mW), 2 Joule (J) per point, 4 J/cm² , 10 points per session, Group 2 will receive PDO thread and PBM sham. A total of 40 patients with glabellar wrinkle, aged 30 to 60 will be included. The treatments will consist of 9 sessions, twice a week for 30 days. The oedema and dermal thickness will be evaluated by linear ultrasound (10-14 MegaHertz (MHz), Mobisson). Photographic records will also be made.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date August 23, 2023
Est. primary completion date February 17, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 60 Years
Eligibility Inclusion Criteria: - both genders - aged between 30 and 60 years, - Fitzpatrick skin phototype I - IV, - levels 3 and 4 in the aging classification according to Glogau, - presenting glabellar static wrinkles (permanent wrinkles) - who do not have uncompensated comorbidities. Exclusion Criteria: - decompensated diabetes, lupus, HIV positive, hepatitis, high blood pressure, neurological disorders, active neoplasms, - tendency to develop keloids, - menopause, pregnant women, - participants who have absorbable threads (applied less than 3 months ago) or definitive at glabella, - who have PMMA (polymethylmethacrylate) application in any region of the face, - who are undergoing treatment with any type of laser therapy in any areas of the body, - participants who are undergoing aesthetic or dermatological treatment on the face, - participants who are using anti-inflammatories and corticoids in a window of 30 days before and after the procedure, - participants using isotretinoin in the last 6 months.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Photobiomodulation
Patient will receive the application of the low-power 660 nm Newskin MMO red LED in the immediate postoperative period. The application will be made punctually over the entire length of the wire, which measures 5 cm, totaling 10 application points with 1 cm of distance between them. The LED application will be repeated twice a week, with a minimum interval of 48 hours, totaling 9 laser applications over 30 days.
Procedure:
PDO thread
The participant's face will be cleaned with a 0.2% chlorhexidine solution. 0.1 ml of injectable anesthetic (2% lidocaine hydrochloride without vasoconstrictor, XYlestesin) will be administered in the skin layer at the point of incision in the glabellar region with a 30-gauge needle. A subincision will be made with a 21-gauge cannula in the glabellar ridge and then an injectable thread will be applied in the deep dermal layer below the glabellar ridge in the same direction as it.

Locations

Country Name City State
Brazil Clinic Cursos São Paulo SP

Sponsors (1)

Lead Sponsor Collaborator
University of Nove de Julho

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Edema assessed by Ultrasound Ultrasound transversal measurement from epidermis to the beginning of muscle tissue. Before treatment (day 0)
Primary Edema assessed by Ultrasound Ultrasound transversal measurement from epidermis to the beginning of muscle tissue. 24 hours after PDO thread application (day 1)
Secondary dermis thickness Ultrasound transversal measurement from epidermis to the beginning of muscle tissue. Before treatment (day 0)
Secondary dermis thickness Ultrasound transversal measurement from epidermis to the beginning of muscle tissue. day 90
Secondary PDO thread hydrolysis Ultrasound identification of presence or absence of the thread day 180
Secondary Photos Image registration of the region treated Before treatment (day 0)
Secondary Photos Image registration of the region treated 24 hours after PDO thread application (day 1)
Secondary Photos Image registration of the region treated day 90
Secondary Photos Image registration of the region treated day 180
See also
  Status Clinical Trial Phase
Completed NCT06003205 - Contributing Factors to Local Bioimpedance Spectroscopy N/A
Completed NCT02055872 - Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial Phase 3
Completed NCT01172522 - Topical Treatment of Under Eye Dark Circles and Swelling Phase 2
Completed NCT00602303 - Bioequivalency Study of Torsemide Tablets Under Fasting Conditions N/A
Completed NCT00602615 - Bioequivalency Study of Torsemide Tablets Under Fed Conditions N/A
Completed NCT00115726 - Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood Pressure Phase 4
Completed NCT04595448 - Lymphatic Function in Patients With Secondary Tricuspid Valve Regurgitation
Recruiting NCT06014203 - Examination of Edema After Arthroscopic Shoulder Surgery
Completed NCT06010394 - Control of Edema in the Knee in Patients With Knee Osteoarthritis N/A
Recruiting NCT05310019 - Effect of Electroacupuncture in Patients Submitted Orthognathic Surgery and Mentoplasty N/A
Recruiting NCT03442166 - Effectiveness of Light-emitting Diode (LED) Photobiomodulation in the Extraction of Retained Lower Third Molars Phase 2
Withdrawn NCT03603990 - Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema N/A
Completed NCT06220903 - The Effect of Complex Decongestive Therapy in Patients With Lymphedema N/A
Recruiting NCT04927234 - Foot and Ankle Post-operative Oedema Management Using Geko™ N/A
Active, not recruiting NCT02876107 - Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer Phase 2
Recruiting NCT03704857 - Different Endodontic Treatment Techniques in Postoperative Symptoms, Apical Repair, Longevity of Rehabilitations, and Oral Health-related Quality of Life N/A
Recruiting NCT04606030 - LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge) N/A
Completed NCT00732719 - Compression Device Safety Study on Edema Phase 2
Not yet recruiting NCT05534308 - Effect of Intraoperative Taping on the Control of Edema Resulting From Stripping N/A
Completed NCT04205253 - Tongue Depressor-related Ischemia-Reperfusion Injury in Tongue